 Home
|
|
Healthcare Professionals
|
|
Media Center
|
|
 |
|
 |
|
|
|
|
||||||
|
print page | |
book mark | |
email page | |
REGRANEX Gel is a prescription drug for the treatment of diabetic neuropathic lower extremity ulcers. It is indicated for the treatment of lower extremity diabetic neuropathic ulcers that extend into the subcutaneous tissue or beyond and have an adequate blood supply. When used as an adjunct to, and not a substitute for, good ulcer care practices including initial sharp debridement, pressure relief and infection control, REGRANEX Gel increases the incidence of complete healing of diabetic ulcers. Please see full U.S. Prescribing Information. |
||
|
||
|
REGRANEX Gel
should not be used in patients with cancers at the site of application.
In a safety study, patients treated with 3 or more tubes of REGRANEX
Gel had an increased risk of death from cancer at locations in the body
other than the ulcer. Talk to your doctor about risks of cancer and
tell your doctor if you have or have had cancer.
© Systagenix Wound Management (US), Inc. 2008. All rights reserved. This site is published by Systagenix Wound Management (US), Inc. which is solely responsible for its contents. This site is intended for U.S. audiences only. Last Updated: 26 September 2007 |
